Provencio, M; Nadal, E; Insa, A; García-Campelo, MR; Casal-Rubio, J; Dómine, M; Majem, M; Rodríguez-Abreu, D; Martínez-Martí, A; Carpeño, JD; Cobo, M; Vivanco, GL; Del Barco, E; Caro, RB; Viñolas, N; Aranda, IB; Viteri, S; Pereira, E; Royuela, A; Casarrubios, M; Antón, CS; Parra, ER; Wistuba, I; Calvo, V; Laza-Briviesca, R; Romero, A; Massuti, B; Cruz-Bermúdez, A – 2020 – 10.1016/S1470-2045(20)30453-8
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial – LANCET ONCOLOGY
por prodriguez | Ene 1, 2020 | Publicaciones - B-22 | 0 Comentarios